Association of plasma Vitamin D metabolites with incident type 2 diabetes: EPIC-InterAct case-cohort study

The InterAct project was funded by the European Union Sixth Framework Program (Grant LSHM_ CT_2006_037197). Biomarker measurements for vitamin D metabolites were funded jointly by the MRC Cambridge Initiative (Grants RG71466 and SJAH/004), and by the EPIC-CVD project. EPIC-CVD has been supported by the European Union Seventh Framework Program (Grant HEALTH-F2-2012- 279233), the European Research Council (Grant 268834), the UK Medical Research Council (Grants G0800270 and MR/L003120/1), the British Heart Foundation (Grants SP/09/002, RG/08/014, and RG13/13/30194), and by the UK National Institutes of Health Research. Additionally, InterAct investigators acknowledge funding from the following agencies: Medical Research Council Epidemiology Unit MC_UU_12015/1 and MC_UU_12015/5, NIHR Biomedical Research Centre Cambridge: Nutrition, Diet, and Lifestyle Research Theme (Grant IS-BRC-1215-20014), the Regional Government of Asturias, and the Regional Governments of Basque Country. I.S. is supported by Junior Dr. Dekker Grant 2015T019 from the Dutch Heart Foundation. G.F. is supported by Agence Nationale de la Recherche via “Investissement d’Avenir” Grant ANR-10- COHO-0006 and by the IDEX Paris Saclay Nutriperso Project. This project has received funding from the European Union’s Horizon 2020 research and innovation program under Marie Sklodowska-Curie Grant 701708.